Trial intelligence / Profile preview

TIC-TOC: Tranexamic Acid in Children with Traumatic Injury

NCT04387305Phase 3Not yet recruiting

Start
Oct 2026
Primary completion
Mar 2031
Modality
Small Molecules
01

Overview

A Phase 3 trial of tranexamic acid in traumatic brain injury (TBI), hemorrhage, traumatic injury. Planned start Oct 2026; status: not yet recruiting.

02

Drugs

tranexamic acid
03

Conditions

traumatic brain injury (TBI)hemorrhagetraumatic injury

Beyond the preview

Go deeper on NCT04387305.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04387305.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call